The therapeutic potential of curculigoside in poststroke depression: a focus on hippocampal neurogenesis and mitochondrial function
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Ning-Xi Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Hippocampus, Neurogenesis, Mitochondria, Stroke. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Construction Funds of Key Medical Disciplines in Longhua District, Shenzhen, Guangdong Basic and Applied Basic Research Foundation, China Postdoctoral Science Foundation.
Themen: Depression
Abstract (Originalsprache)
Objectives
To investigate the effects and mechanism of curculigoside against poststroke depression (PSD).
Methods
In vivo, a PSD rat model was created by combining bilateral common carotid artery occlusion and chronic unpredictable mild stress stimulations. After 4-week modeling and intragastrically administration of curculigoside, the effects of curculigoside on behavior, hippocampal neurogenesis, and hippocampal mitochondrial oxidative phosphorylation (OxPhos) were investigated. In vitro, PSD-like primary neural stem cells (NSCs) model was established by oxygen-glucose deprivation/recovery (OGD/R) combing high-corticosterone (CORT) concentration, followed by treatment with curculigoside. The investigation subsequently examined the impact of curculigoside on mitochondrial OxPhos, proliferation, and differentiation of NSCs under OGD/R + CORT conditions. Key findings In vivo, PSD rats showed significantly depressive behaviors, dysfunctional neurogenesis in hippocampus, as well as decreased hippocampus adenosine triphosphate (ATP) levels, reduced electron transport chain complexes activity, and downregulates mitochondrial transcription factor A (TFAM) and PPAR-gamma coactivator 1 alpha (PGC-1α) expression in hippocampus. In vitro, OGD/R +CORT significantly injured the proliferation and differentiation, as well as impaired the mitochondrial OxPhos in NSCs. Curculigoside treatment was effective in improving these abnormal changes.
Conclusion
Curculigoside may repair hippocampal neurogenesis in PSD rats by enhancing hippocampal mitochondrial OxPhos, and has shown a great potential for anti-PSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- Department of Rehabilitation Medicine, People's Hospital of Longhua, Shenzhen, 518109, China.
ORCID-Profile: Ning-Xi Zeng
Förderung
- Construction Funds of Key Medical Disciplines in Longhua District, Shenzhen
- Guangdong Basic and Applied Basic Research Foundation
- China Postdoctoral Science Foundation
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province Open Project
Zitieren
APA
Zeng, N. X., Chen, X., Yang, X. Y., Chen, D. S., & Shen, M. (2025). The therapeutic potential of curculigoside in poststroke depression: a focus on hippocampal neurogenesis and mitochondrial function. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae091
Vancouver
Zeng NX, Chen X, Yang XY, Chen DS, Shen M. The therapeutic potential of curculigoside in poststroke depression: a focus on hippocampal neurogenesis and mitochondrial function. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae091
BibTeX
@article{Zeng2025,
author = {Zeng, Ning-Xi and Chen, Xin and Yang, Xiao-Yan and Chen, De-Sheng and Shen, Mei},
title = {The therapeutic potential of curculigoside in poststroke depression: a focus on hippocampal neurogenesis and mitochondrial function},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae091}
}
EUVIMED